Immune checkpoint signaling and cancer immunotherapy
Abstract Immune checkpoint blockade therapy has become a major weapon in fighting cancer. Antibody drugs, such as anti-PD-1 and anti-PD-L1, demonstrate obvious advantages such as broad applicability across cancer types and durable clinical response when treatment is effective. However, the overall r...
Sábháilte in:
| Príomhchruthaitheoirí: | , |
|---|---|
| Formáid: | Revisão |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
2020
|
| Rochtain ar líne: | https://doi.org/10.1038/s41422-020-0343-4 https://www.nature.com/articles/s41422-020-0343-4.pdf |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|